Javier Torres
Internal Medicine · Mayaguez, PRNPI 1063935039
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 223 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AstraZeneca at 27.1% of the total. 2025 is the largest year on record at $3,173, more than ten times the $165 reported in 2020. Among internal medicine clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 223 payments — averaging $45.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Boehringer Ingelheim$1K
- United Therapeutics Corporation$1K
- Bayer$679
- Boston Scientific$600
- Johnson & Johnson$509
- plus $3K from 21 others
What the payments were for
- Food & beverage$9,80697%
- Education$3013%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 61 | $2,742 |
| Boehringer Ingelheim | 29 | $1,186 |
| United Therapeutics Corporation | 11 | $1,040 |
| Bayer | 8 | $679 |
| Boston Scientific | 11 | $600 |
| Johnson & Johnson | 21 | $509 |
| GSK | 9 | $381 |
| Jazz Pharmaceuticals Inc. | 7 | $352 |
| Merck | 10 | $305 |
| Sanofi | 9 | $303 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $222 |
| Amgen | 5 | $221 |
| E.r. Squibb & Sons, L.L.C. | 5 | $202 |
| Actelion Pharmaceuticals US, Inc. | 2 | $201 |
| Caris MPI, Inc. | 3 | $186 |
| Sanofi-aventis U.S. LLC | 2 | $184 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $153 |
| PBG Puerto Rico LLC | 8 | $143 |
| Lilly USA, LLC | 1 | $102 |
| Tempus AI, Inc | 1 | $100 |
| Eli Lilly Export S.A. Puerto Rico Branch | 3 | $77 |
| Mylan Specialty L.p. | 1 | $76 |
| Abbott | 1 | $50 |
| Viatris Specialty LLC | 2 | $36 |
| Chiesi USA, Inc. | 2 | $31 |
| Novartis | 1 | $16 |
| Bayer Puerto Rico Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEZSPIRE$750
- FASENRA$464
- TYVASO$377
- OFEV$353
- Adempas$249
- AIRSUPRA$238
- XYWAV$235
- MI CANCER SEEK$145
- STEEN Solution$129
- NUCALA$125
- CUVITRU$122
- BREZTRI$121
- Repatha$119
- ELIQUIS$118
- EMBLEM MRI S-ICD$112
- WATCHMAN Access System$110
- ORENITRAM$108
- REMODULIN$108
- DUPIXENT$105
- Kerendia$104
How this compares
$10,107 in reported general payments places this provider in the 95th percentile of 1,043 internal medicine providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 11 | $143,173 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $7,314 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $599 |
| Montelukast Sodium | 14 | $84 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev | $1,186 | $143,17311 claims |
| GSKTrelegy Ellipta | $381 | $7,31411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,043 internal medicine providers in Puerto Rico.
Other internal medicine in Mayaguez
- Nelson VallejoLas Piedras$621K
- Ricardo FernandezSan Juan$351K
- Ronald Collazo PaganManati$206K
- Angel VinuelaDorado$182K
- Julio JimenezSan Lorenzo$99K
- Luis Negron GarciaSan German$24K
- Jorge Torres OlmedaCoto Laurel$23K
- Norma SalgadoSan Juan$21K
- Victor Gordo GonzalezSan Juan$21K
- Luis Rivera ColonRio Piedras$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.